H. Puolijoki, J. Mustonen, E. Pettersson, A. Pasternack, and A. Lahdensuo, Proteinuria and Haematuria are Frequently Present in Patients with Lung Cancer, Nephrology Dialysis Transplantation, vol.4, issue.11, pp.947-950, 1989.
DOI : 10.1093/ndt/4.11.947

N. Sawyer, J. Wadsworth, M. Wijnen, and R. Gabriel, Prevalence, concentration, and prognostic importance of proteinuria in patients with malignancies, BMJ, vol.296, issue.6632, pp.1295-1298, 1988.
DOI : 10.1136/bmj.296.6632.1295

J. Lee, H. Yamauchi, J. Hopper, and . Jr, The Association of Cancer and the Nephrotic Syndrome, Annals of Internal Medicine, vol.64, issue.1, pp.41-51, 1966.
DOI : 10.7326/0003-4819-64-1-41

S. Birkeland and H. Storm, Glomerulonephritis and malignancy: A population-based analysis, Kidney International, vol.63, issue.2, pp.716-721, 2003.
DOI : 10.1046/j.1523-1755.2003.00771.x

L. Jørgensen, I. Heuch, T. Jenssen, and B. Jacobsen, Association of Albuminuria and Cancer Incidence, Journal of the American Society of Nephrology, vol.19, issue.5, pp.992-998, 2008.
DOI : 10.1681/ASN.2007060712

R. Glassock, The Pathogenesis of Idiopathic Membranous Nephropathy: A 50-Year Odyssey, American Journal of Kidney Diseases, vol.56, issue.1, pp.157-167, 2010.
DOI : 10.1053/j.ajkd.2010.01.008

D. Burstein, S. Korbet, and M. Schwartz, Membranous Glomerulonephritis and Malignancy, American Journal of Kidney Diseases, vol.22, issue.1, pp.5-10, 1993.
DOI : 10.1016/S0272-6386(12)70160-9

C. Lefaucheur, B. Stengel, D. Nochy, P. Martel, G. Hill et al., Membranous nephropathy and cancer: Epidemiologic evidence and determinants of high-risk cancer association, Kidney International, vol.70, issue.8, pp.1510-1517, 2006.
DOI : 10.1038/sj.ki.5001790

C. Alpers and R. Cotran, Neoplasia and glomerular injury, Kidney International, vol.30, issue.4, pp.465-473, 1986.
DOI : 10.1038/ki.1986.209

J. Bacchetta, L. Juillard, P. Cochat, and J. Droz, Paraneoplastic glomerular diseases and malignancies, Critical Reviews in Oncology/Hematology, vol.70, issue.1, pp.39-58, 2009.
DOI : 10.1016/j.critrevonc.2008.08.003

P. Ronco, Paraneoplastic glomerulopathies: New insights into an old entity, Kidney International, vol.56, issue.1, pp.355-377, 1999.
DOI : 10.1046/j.1523-1755.1999.00548.x

J. Eagen, Glomerulopathies of neoplasia, Kidney International, vol.11, issue.5, pp.297-303, 1977.
DOI : 10.1038/ki.1977.47

R. Bjørneklett, B. Vikse, E. Svarstad, K. Aasarød, L. Bostad et al., Long-Term Risk of Cancer in Membranous Nephropathy Patients, American Journal of Kidney Diseases, vol.50, issue.3, pp.396-403, 2007.
DOI : 10.1053/j.ajkd.2007.06.003

L. Beck and . Jr, Membranous Nephropathy and Malignancy, Seminars in Nephrology, vol.30, issue.6, pp.635-644, 2010.
DOI : 10.1016/j.semnephrol.2010.09.011

L. Beck, . Jr, R. Bonegio, G. Lambeau, D. Beck et al., Receptor as Target Antigen in Idiopathic Membranous Nephropathy, New England Journal of Medicine, vol.361, issue.1, pp.11-21, 2009.
DOI : 10.1056/NEJMoa0810457
URL : https://hal.archives-ouvertes.fr/hal-00417718

E. Hoxha, S. Harendza, G. Zahner, U. Panzer, O. Steinmetz et al., An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis, Nephrology Dialysis Transplantation, vol.26, issue.8, pp.2526-2532, 2011.
DOI : 10.1093/ndt/gfr247

P. Ronco and H. Debiec, Pathogenesis of membranous nephropathy: recent advances and future challenges, Nature Reviews Nephrology, vol.181, issue.4, pp.203-213
DOI : 10.1007/s00467-006-0203-6
URL : https://hal.archives-ouvertes.fr/inserm-00919135

H. Debiec and P. Ronco, Nephrotic syndrome: A new specific test for idiopathic membranous nephropathy, Nature Reviews Nephrology, vol.77, pp.496-498, 2011.
DOI : 10.1038/nrneph.2011.106

W. Qin, L. Beck, . Jr, C. Zeng, Z. Chen et al., Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy, Journal of the American Society of Nephrology, vol.22, issue.6, pp.1137-1143, 2011.
DOI : 10.1681/ASN.2010090967

H. Ohtani, H. Wakui, A. Komatsuda, S. Okuyama, R. Masai et al., Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy, Nephrology Dialysis Transplantation, vol.19, issue.3, pp.574-579, 2004.
DOI : 10.1093/ndt/gfg616

Z. Qu, G. Liu, J. Li, L. Wu, Y. Tan et al., Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy, Nephrology Dialysis Transplantation, vol.27, issue.5, pp.1931-1937
DOI : 10.1093/ndt/gfr534

J. Mustonen, A. Pasternack, and H. Helin, IgA Mesangial Nephropathy in Neoplastic Diseases1, Contrib Nephrol, vol.40, pp.283-291, 1984.
DOI : 10.1159/000409763

T. Magyarlaki, B. Kiss, I. Buzogány, A. Fazekas, F. Sü-kö-sd et al., Renal Cell Carcinoma and Paraneoplastic IgA Nephropathy, Nephron, vol.82, issue.2, pp.127-130, 1999.
DOI : 10.1159/000045388

T. Pankhurst, C. Savage, C. Gordon, and L. Harper, Malignancy is increased in ANCA-associated vasculitis, Rheumatology, vol.43, issue.12, pp.1532-1535, 2004.
DOI : 10.1093/rheumatology/keh374

E. Pertuiset, F. Lioté, E. Launay-russ, F. Kemiche, I. Cerf-payrastre et al., Adult Henoch-Sch??nlein purpura associated with malignancy, Seminars in Arthritis and Rheumatism, vol.29, issue.6, pp.360-367, 2000.
DOI : 10.1053/sarh.2000.6988

E. Pillebout, E. Thervet, G. Hill, C. Alberti, P. Vanhille et al., Henoch-Schonlein Purpura in Adults: Outcome and Prognostic Factors, Journal of the American Society of Nephrology, vol.13, issue.5, pp.1271-1278, 2002.
DOI : 10.1097/01.ASN.0000013883.99976.22

J. Whitworth, L. Morel-maroger, F. Mignon, and G. Richet, The Significance of Extracapillary Proliferation, Nephron, vol.16, issue.1, pp.1-19, 1976.
DOI : 10.1159/000180578

C. Biava, T. Gonwa, J. Naughton, J. Hopper, and . Jr, Crescentic Glomerulonephritis Associated with Nonrenal Malignancies, American Journal of Nephrology, vol.4, issue.4, pp.208-214, 1984.
DOI : 10.1159/000166810

E. Tatsis, E. Reinhold-keller, K. Steindorf, A. Feller, and W. Gross, Wegener's granulomatosis associated with renal cell carcinoma, Arthritis & Rheumatism, vol.37, issue.4, pp.751-756, 1999.
DOI : 10.1002/1529-0131(199904)42:4<751::AID-ANR19>3.0.CO;2-D

P. Vanatta, F. Silva, W. Taylor, and J. Costa, Renal cell carcinoma and systemic amyloidosis: Demonstration of AA protein and review of the literature, Human Pathology, vol.14, issue.3, pp.195-201, 1983.
DOI : 10.1016/S0046-8177(83)80016-1

R. Glassock, Secondary minimal change disease, Nephrology Dialysis Transplantation, vol.18, issue.90006, pp.52-58, 2003.
DOI : 10.1093/ndt/gfg1060

A. Karras, V. De-montpreville, F. Fakhouri, J. Grü-nfeld, and P. Lesavre, Renal and thymic pathology in thymoma-associated nephropathy: report of 21 cases and review of the literature, Nephrology Dialysis Transplantation, vol.20, issue.6, pp.1075-1082, 2005.
DOI : 10.1093/ndt/gfh615

J. Plager and L. Stutzman, Acute nephrotic syndrome as a manifestation of active Hodgkin's disease, The American Journal of Medicine, vol.50, issue.1, pp.56-66, 1971.
DOI : 10.1016/0002-9343(71)90205-1

P. Kramer, W. Sizoo, and E. Twiss, Nephrotic syndrome in Hodgkin's disease. Report of five cases and review of the literature, Neth J Med, vol.24, pp.114-119, 1981.

E. Franklin, M. Pras, M. Levin, and B. Frangione, The partial amino acid sequence of the major low molecular weight component of two human amyloid fibrils, FEBS Letters, vol.174, issue.1, pp.121-123, 1972.
DOI : 10.1016/0014-5793(72)80235-7

V. Audard, F. Larousserie, P. Grimbert, M. Abtahi, J. Sotto et al., Minimal change nephrotic syndrome and classical Hodgkin's lymphoma: Report of 21 cases and review of the literature, Kidney International, vol.69, issue.12, pp.2251-2260, 2006.
DOI : 10.1038/sj.ki.5000341

A. Moorthy, S. Zimmerman, and P. Burkholder, Nephrotic syndrome in Hodgkin's disease, The American Journal of Medicine, vol.61, issue.4, pp.471-477, 1976.
DOI : 10.1016/0002-9343(76)90325-9

R. Shalhoub, PATHOGENESIS OF LIPOID NEPHROSIS: A DISORDER OF T-CELL FUNCTION, The Lancet, vol.304, issue.7880, pp.556-560, 1974.
DOI : 10.1016/S0140-6736(74)91880-7

P. Grimbert, A. Valanciute, V. Audard, A. Pawlak, S. Le-gouvelo et al., Truncation of Cmip (Tc-mip), a new proximal signaling protein, induces c-maf Th2 transcription factor and cytoskeleton reorganization
URL : https://hal.archives-ouvertes.fr/inserm-00000005

S. Zhang, M. Kamal, K. Dahan, A. Pawlak, V. Ory et al., c-mip Impairs Podocyte Proximal Signaling and Induces Heavy Proteinuria, Science Signaling, vol.3, issue.122, p.39, 2010.
DOI : 10.1126/scisignal.2000678
URL : https://hal.archives-ouvertes.fr/inserm-00489747

V. Audard, S. Zhang, C. Copie-bergman, C. Rucker-martin, V. Ory et al., Occurrence of minimal change nephrotic syndrome in classical Hodgkin lymphoma is closely related to the induction of c-mip in Hodgkin-Reed Sternberg cells and podocytes, Blood, vol.115, issue.18, pp.3756-3762, 2010.
DOI : 10.1182/blood-2009-11-251132
URL : https://hal.archives-ouvertes.fr/inserm-00485558

J. Bergmann, D. Buchheidt, R. Waldherr, O. Maywald, F. Van-der-woude et al., IgA nephropathy and hodgkin???s disease: A rare coincidence. Case report and literature review, American Journal of Kidney Diseases, vol.45, issue.1, pp.16-19, 2005.
DOI : 10.1053/j.ajkd.2004.09.007

A. Bradwell, H. Carr-smith, G. Mead, L. Tang, P. Showell et al., Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine, Clin Chem, vol.47, pp.673-680, 2001.

J. Katzmann, R. Clark, R. Abraham, S. Bryant, J. Lymp et al., Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: Relative sensitivity for detection of monoclonal light chains, Clin Chem, vol.48, pp.1437-1444, 2002.

F. Seney, . Jr, W. Federgreen, H. Stein, and M. Kashgarian, A Review of Nephrotic Syndrome Associated With Chronic Lymphocytic Leukemia, Archives of Internal Medicine, vol.146, issue.1, pp.137-141, 1986.
DOI : 10.1001/archinte.1986.00360130167023

B. Moulin, P. Ronco, B. Mougenot, A. François, J. Fillastre et al., Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas, Kidney International, vol.42, issue.1, pp.127-135, 1992.
DOI : 10.1038/ki.1992.270

S. Nasr, A. Satoskar, G. Markowitz, A. Valeri, G. Appel et al., Proliferative Glomerulonephritis with Monoclonal IgG Deposits, Journal of the American Society of Nephrology, vol.20, issue.9, pp.2055-2064, 2009.
DOI : 10.1681/ASN.2009010110

J. Brouet, J. Clauvel, F. Danon, M. Klein, and M. Seligmann, Biologic and clinical significance of cryoglobulins, The American Journal of Medicine, vol.57, issue.5, pp.775-788, 1974.
DOI : 10.1016/0002-9343(74)90852-3

R. Randall, W. Williamson, . Jr, F. Mullinax, M. Tung et al., Manifestations of systemic light chain deposition, The American Journal of Medicine, vol.60, issue.2, pp.293-299, 1976.
DOI : 10.1016/0002-9343(76)90440-X

F. Bridoux, V. Hugue, O. Coldefy, J. Goujon, M. Bauwens et al., Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features, Kidney International, vol.62, issue.5, pp.1764-1775, 2002.
DOI : 10.1046/j.1523-1755.2002.00628.x

S. Nasr, G. Markowitz, M. Stokes, S. Seshan, E. Valderrama et al., Proliferative glomerulonephritis with monoclonal IgG deposits: A distinct entity mimicking immune-complex glomerulonephritis, Kidney International, vol.65, issue.1, pp.85-96, 2004.
DOI : 10.1111/j.1523-1755.2004.00365.x

E. Guiard, A. Karras, E. Plaisier, D. Van-huyen, J. Fakhouri et al., Patterns of Noncryoglobulinemic Glomerulonephritis with Monoclonal Ig Deposits: Correlation with IgG Subclass and Response to Rituximab, Clinical Journal of the American Society of Nephrology, vol.6, issue.7, pp.1609-1616, 2011.
DOI : 10.2215/CJN.10611110

S. Sethi, L. Zand, N. Leung, R. Smith, D. Jevremonic et al., Membranoproliferative Glomerulonephritis Secondary to Monoclonal Gammopathy, Clinical Journal of the American Society of Nephrology, vol.5, issue.5, pp.770-782, 2010.
DOI : 10.2215/CJN.06760909

L. Morel-maroger, A. Basch, F. Danon, P. Verroust, and G. Richet, Pathology of the Kidney in Waldenstr??m's Macroglobulinemia, New England Journal of Medicine, vol.283, issue.3, pp.123-129, 1970.
DOI : 10.1056/NEJM197007162830304

N. Da-'as, Y. Kleinman, A. Polliack, G. Amir, Z. Ne-'eman et al., Immunotactoid glomerulopathy with massive bone marrow deposits in a patient with IgM kappa monoclonal gammopathy and hypocomplementemia, American Journal of Kidney Diseases, vol.38, issue.2, pp.395-399, 2001.
DOI : 10.1053/ajkd.2001.26108

B. Dussol, G. Kaplanski, L. Daniel, P. Brunet, J. Pellissier et al., Simultaneous occurrence of fibrillary glomerulopathy and AL amyloid, Nephrology Dialysis Transplantation, vol.13, issue.10, pp.2630-2632, 1998.
DOI : 10.1093/ndt/13.10.2630

Y. Tomiyoshi, T. Sakemi, Y. Yoshikawa, T. Shimokama, and T. Watanabe, Fibrillar crystal structure in essential monoclonal IgM kappa cryoglobulinemia, Clin Nephrol, vol.49, pp.325-327, 1998.

A. Meyrier, P. Simon, F. Mignon, L. Striker, and M. Ramée, Rapidly Progressive (???Crescentic???) Glomerulonephritis and Monoclonal Gammapathies, Nephron, vol.38, issue.3, pp.156-162, 1984.
DOI : 10.1159/000183299

I. Garcia-pacheco, A. Khan, and K. Venkat, Rapidly progressive glomerulonephritis in a patient with Waldenstr, Clinical Nephrology, vol.64, issue.11, pp.396-399, 2005.
DOI : 10.5414/CNP64396

Y. Nakamoto, H. Imai, S. Hamanaka, K. Yoshida, T. Akihama et al., IgM Monoclonal Gammopathy Accompanied by Nodular Glomerulosclerosis, Urine-Concentrating Defect, and Hyporeninemic Hypoaldosteronism, American Journal of Nephrology, vol.5, issue.1, pp.53-58, 1985.
DOI : 10.1159/000166905

V. Audard, B. Georges, P. Vanhille, C. Toly, B. Deroure et al., Renal Lesions Associated with IgM-Secreting Monoclonal Proliferations: Revisiting the Disease Spectrum, Clinical Journal of the American Society of Nephrology, vol.3, issue.5, pp.1339-1349, 2008.
DOI : 10.2215/CJN.01600408
URL : https://hal.archives-ouvertes.fr/inserm-00326630

G. Glenner, W. Terry, M. Harada, C. Isersky, and D. Page, Amyloid Fibril Proteins: Proof of Homology with Immunoglobulin Light Chains by Sequence Analyses, Science, vol.172, issue.3988, pp.1150-1151, 1971.
DOI : 10.1126/science.172.3988.1150

B. Iványi, Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma, Arch Pathol Lab Med, vol.114, pp.986-987, 1990.

G. Herrera, L. Joseph, X. Gu, A. Hough, and B. Barlogie, Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia, Arch Pathol Lab Med, vol.128, pp.875-879, 2004.

P. Ronco, E. Plaisier, B. Mougenot, and P. Aucouturier, Immunoglobulin Light (Heavy)-Chain Deposition Disease: From Molecular Medicine to Pathophysiology-Driven Therapy, Clinical Journal of the American Society of Nephrology, vol.1, issue.6, pp.1342-1350, 2006.
DOI : 10.2215/CJN.01730506
URL : https://hal.archives-ouvertes.fr/inserm-00169567

D. Ganeval, L. Noël, J. Preud-'homme, D. Droz, and J. Grü-nfeld, Light-chain deposition disease: Its relation with AL-type amyloidosis, Kidney International, vol.26, issue.1, pp.1-9, 1984.
DOI : 10.1038/ki.1984.126

P. Went, S. Ascani, E. Strøm, S. Brorson, M. Musso et al., Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease, The Lancet Oncology, vol.5, issue.6, pp.381-383, 2004.
DOI : 10.1016/S1470-2045(04)01495-0

J. Teng, W. Russell, X. Gu, J. Cardelli, M. Jones et al., Different types of glomerulopathic light chains interact with mesangial cells using a common receptor but exhibit different intracellular trafficking patterns, Laboratory Investigation, vol.84, issue.4, pp.440-451, 2004.
DOI : 10.1038/labinvest.3700069

J. Keeling and G. Herrera, Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage, Kidney International, vol.68, issue.4, pp.1590-1603, 2005.
DOI : 10.1111/j.1523-1755.2005.00571.x

P. Ronco, M. Alyanakian, B. Mougenot, and P. Aucouturier, Light chain deposition disease: A model of glomerulosclerosis defined at the molecular level, J Am Soc Nephrol, vol.12, pp.1558-1565, 2001.

D. Droz, L. Noel, F. Carnot, F. Degos, D. Ganeval et al., Liver involvement in nonamyloid light chain deposits disease, Lab Invest, vol.50, pp.683-689, 1984.

J. Buxbaum, J. Chuba, G. Hellman, A. Solomon, and G. Gallo, Monoclonal Immunoglobulin Deposition Disease: Light Chain and Light and Heavy Chain Deposition Diseases and Their Relation to Light Chain Amyloidosis, Annals of Internal Medicine, vol.112, issue.6, pp.455-464, 1990.
DOI : 10.7326/0003-4819-76-3-112-6-455

R. Heilman, J. Velosa, K. Holley, K. Offord, and R. Kyle, Long-Term Follow-Up and Response to Chemotherapy in Patients With Light-Chain Deposition Disease, American Journal of Kidney Diseases, vol.20, issue.1, pp.34-41, 1992.
DOI : 10.1016/S0272-6386(12)80314-3

N. Kambham, G. Markowitz, G. Appel, M. Kleiner, P. Aucouturier et al., Heavy chain deposition disease: The disease spectrum, American Journal of Kidney Diseases, vol.33, issue.5, pp.954-962, 1999.
DOI : 10.1016/S0272-6386(99)70432-4

J. Lin, G. Markowitz, A. Valeri, N. Kambham, W. Sherman et al., Renal monoclonal immunoglobulin deposition disease: The disease spectrum, J Am Soc Nephrol, vol.12, pp.1482-1492, 2001.

R. Masai, H. Wakui, M. Togashi, N. Maki, H. Ohtani et al., Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease, Clinical Nephrology, vol.71, issue.01, pp.9-20, 2009.
DOI : 10.5414/CNP71009

S. Nasr, A. Valeri, L. Cornell, M. Fidler, S. Sethi et al., Renal Monoclonal Immunoglobulin Deposition Disease: A Report of 64 Patients from a Single Institution, Clinical Journal of the American Society of Nephrology, vol.7, issue.2, pp.231-239
DOI : 10.2215/CJN.08640811

P. Aucouturier, A. Khamlichi, G. Touchard, E. Justrabo, M. Cogne et al., Heavy-Chain Deposition Disease, New England Journal of Medicine, vol.329, issue.19, pp.1389-1393, 1993.
DOI : 10.1056/NEJM199311043291905

A. Katz, R. Zent, and J. Bargman, IgG heavy-chain deposition disease, Mod Pathol, vol.7, pp.874-878, 1994.

T. Yasuda, K. Fujita, H. Imai, K. Morita, Y. Nakamoto et al., Gamma-heavy chain deposition disease showing nodular glomerulosclerosis, Clin Nephrol, vol.44, pp.394-399, 1995.

A. Herzenberg, L. J. Magil, and A. , Monoclonal heavy chain (immunoglobulin G3) deposition disease: report of a case, American Journal of Kidney Diseases, vol.28, issue.1, pp.128-131, 1996.
DOI : 10.1016/S0272-6386(96)90141-9

I. Cheng, S. Ho, D. Chan, W. Ng, and K. Chan, Crescentic nodular glomerulosclerosis secondary to truncated immunoglobulin ?? heavy chain deposition, American Journal of Kidney Diseases, vol.28, issue.2, pp.283-288, 1996.
DOI : 10.1016/S0272-6386(96)90315-7

G. Husby, P. Blichfeldt, L. Brinch, P. Brandtzaeg, O. Mellbye et al., Chronic arthritis and g heavy chain disease: Coincidence or pathogenic link, Scand J Rheumatol, vol.27, pp.257-264, 1998.

T. Rott, A. Vizjak, J. Lindic, A. Hvala, T. Perkovic et al., IgG heavy-chain deposition disease affecting kidney, skin, and skeletal muscle, Nephrology Dialysis Transplantation, vol.13, issue.7, pp.1825-1828, 1998.
DOI : 10.1093/ndt/13.7.1825

J. Polski, N. Galvin, and L. Salinas-madrigal, Non-amyloid fibrils in heavy chain deposition disease, Kidney International, vol.56, issue.4, pp.1601-1602, 1999.
DOI : 10.1046/j.1523-1755.1999.00713.x

B. Moulin, S. Deret, X. Mariette, O. Kourilsky, H. Imai et al., Nodular glomerulosclerosis with deposition of monoclonal immunoglobulin heavy chains lacking C(H)1, J Am Soc Nephrol, vol.10, pp.519-528, 1999.

H. Liapis, I. Papadakis, and L. Nakopoulou, Nodular glomerulosclerosis secondary to ?? heavy chain deposits, Human Pathology, vol.31, issue.1, pp.122-125, 2000.
DOI : 10.1016/S0046-8177(00)80209-9

A. Vedder, J. Weening, and R. Krediet, Intracapillary proliferative glomerulonephritis due to heavy chain deposition disease, Nephrology Dialysis Transplantation, vol.19, issue.5, pp.1302-1304, 2004.
DOI : 10.1093/ndt/gfg575

J. Soma, K. Sato, T. Sakuma, H. Saito, H. Sato et al., Immunoglobulin gamma3-heavy-chain deposition disease: Report of a case and relationship with hypocomplementemia, Am J Kidney Dis, vol.43, pp.10-16, 2004.

J. Soma, Y. Tsuchiya, T. Sakuma, and H. Sato, Clinical remission and histopathological resolution of nodular lesions in a patient with ??3 heavy-chain deposition disease, Clinical Nephrology, vol.69, issue.05, pp.383-386, 2008.
DOI : 10.5414/CNP69383

Y. Oe, I. Nakaya, M. Yahata, T. Sakuma, H. Sato et al., A Case of ?? 1-Heavy Chain Deposition Disease Successfully Treated with Melphalan and Prednisolone Therapy, Internal Medicine, vol.49, issue.14, pp.1411-1415, 2010.
DOI : 10.2169/internalmedicine.49.3499

P. Ronco, E. Plaisier, and P. Aucouturier, Ig-Related Renal Disease in Lymphoplasmacytic Disorders: An Update, Seminars in Nephrology, vol.30, issue.6, pp.557-569, 2010.
DOI : 10.1016/j.semnephrol.2010.09.004

P. Ronco, F. Bridoux, P. Aucouturier, E. Neilson, B. Molitoris et al., Monoclonal gammopathies: Multiple myeloma, amyloidosis, and related disorders) amyloidosis: Diagnosis and treatment, Diseases of the Kidney press 95. Sanchorawala V: Light-chain, pp.1331-1341, 2006.

W. Au, K. Chan, S. Lui, C. Lam, and Y. Kwong, Focal segmental glomerulosclerosis and mesangial sclerosis associated with myeloproliferative disorders, American Journal of Kidney Diseases, vol.34, issue.5, pp.889-893, 1999.
DOI : 10.1016/S0272-6386(99)70047-8

S. Said, N. Leung, S. Sethi, L. Cornell, M. Fidler et al., Myeloproliferative neoplasms cause glomerulopathy, Kidney International, vol.80, issue.7, pp.753-759, 2011.
DOI : 10.1038/ki.2011.147